Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen

This study has been withdrawn prior to enrollment.

(Sponsor has decided to not proceed with this study.)

Sponsor:

Collaborator:

Genentech, Inc.

Information provided by:

Abbott

ClinicalTrials.gov Identifier:

NCT00918450

First received: May 22, 2009

Last updated: February 25, 2010

Last verified: February 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)